Northern Biologics
Toronto
About Northern Biologics
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. Its therapeutic antibody candidates are derived from a state-of-the-art phage display platform developed and refined by world-leading researchers at the University of Toronto, and we focus on developing novel functional modulators of key signaling pathways in cancer and fibrosis. Northern Biologics was founded in 2014 and headquartered in Toronto, Ontario, Canada.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.3M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2019)
- Website: northernbiologics.com
- Phone: +1 (416)634-7132
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/northern-biologics-2234252 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.